Intrinsic Value of S&P & Nasdaq Contact Us

Hemogenyx Pharmaceuticals Plc HOPHF

Other OTC

SharesGrow Score
11/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Hemogenyx Pharmaceuticals Plc (HOPHF) current share price is $2.33. The gold spot price is $4,825.20 per troy ounce. Using the formula: HOPHF in gold = $2.33 × 31.1035 ÷ $4,825.20 = 0.0150 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of HOPHF when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding HOPHF shares over the measured period.

HOPHF in US Dollars
Gold in US Dollars
HOPHF in Gold (grams per share)

Real Wealth Growth Rate

HOPHF
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{HOPHF}_{\text{gold}}(t) = \frac{P_{\text{HOPHF}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{HOPHF}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{HOPHF}_{\text{gold}}^{(T)}}{\text{HOPHF}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{HOPHF}_\text{gold}^{(0)}$ = initial gold-price, $\text{HOPHF}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

CELC
CELC
Celcuity Inc.
$123.47
+2.17%
ELVN
ELVN
Enliven Therapeutics, Inc.
$43.95
-2.01%
INBX
INBX
Inhibrx Biosciences, Inc.
$83.60
+0.49%
GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$18.23
+4.17%
MNPR
MNPR
Monopar Therapeutics Inc.
$57.91
-0.02%
STTK
STTK
Shattuck Labs, Inc.
$7.17
+5.75%
ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
PRLD
PRLD
Prelude Therapeutics Incorporated
$5.52
+25.45%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message